Why is Venmax Drugs falling/rising?

As of 24-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 29.71, reflecting a rise of Rs 1.31 or 4.61%. The stock has shown strong performance, gaining 48.85% over the last nine days and outperforming its sector by 5% today. It opened with a 5% gain and reached an intraday high of Rs 29.82. Additionally, the stock is trading above its moving averages across various time frames, indicating a bullish trend. The recent increase in delivery volume, which rose by 69.77% against the five-day average, suggests rising investor participation, contributing positively to the stock's momentum. There are no positive or negative factors explicitly mentioned that could impact the stock's recent movement.
Broader Market Context: In comparison to the benchmark Sensex, which has only increased by 0.31% over the past week, Venmax Drugs has significantly outperformed with a return of 16.78%. Over the past month, the stock has risen by 24.26%, while the Sensex has only gained 3.05%. This substantial outperformance in both the short-term and year-to-date returns, where Venmax has increased by 64.69% compared to the Sensex's 7.77%, highlights the stock's strong relative strength in the market.